Why do most healthcare AI platforms fail?
I watched a Stripe dashboard hit a million dollars in a single day once.
This was years ago, a different company, a DTC brand we'd built that exploded faster than anyone expected. I should have been thrilled. Mostly I was nauseous. Because I knew the product had problems and scale was about to make them worse.
Scale hides problems. Then it amplifies them. Then it kills you.
I think about this every time I read another "Top 10 AI Platforms for Healthcare" listicle. (No shade, those posts are useful for a market scan.) Most of those platforms are going to disappear in 18 months, and not because the technology is bad. The technology is fine. They're going to disappear because they're trying to be everything to everyone in a market that punishes generality.
What does a healthcare AI platform actually need to do?
One thing, ferociously well. Not ten.
The standard pitch deck for a 2026 healthcare AI platform lists ten workflow automations: AI scribes, medical coding, billing, triage, imaging review, appointment scheduling, patient intake, prior auth, pharmacy automation, voice agents. (Sully's piece is a good map of where the noise is right now.)
Sounds impressive on a slide. Sounds horrifying if you've ever sold to a CMO. Because the CMO's job is to not get sued, and a platform that touches ten workflows has ten attack surfaces for things to go wrong.
The platforms that survive past Series B do one workflow with surgical depth. Scribe. Or coding. Or follow-up. Pick a lane.
How do you know if a platform is AI-native or just rebranded?
Look at the architecture, not the marketing. Is it actually built around the model, or is it a SaaS app from 2019 with a GPT wrapper bolted on?
Two tests I use. First, can it run without an external LLM dependency? Most platforms can't. They're essentially OpenAI wrappers with a HIPAA BAA, which means your patient data is shuttling through a third party, which means one outage at the model provider takes your hospital offline. (It's happened more than once. People forget.)
Second, does the workflow change when the model gets better? Or does the model just generate prettier output inside the same old form fields? AI-native platforms collapse the form. Wrapper platforms can't.
HANA is fully self-hosted with no OpenAI dependency, which sounds like a small thing until your hospital's CIO does the third-party data flow diagram and the colour goes out of their face.
Why don't most healthcare AI projects make it past pilot?
Because the pilot was designed to succeed, not to scale.
I've seen this movie. The platform's CSM picks 50 friendly patients, hand-tunes the prompts, monitors every call, and the pilot delivers gorgeous metrics. Everyone celebrates. Then the platform tries to handle 5,000 patients across three EHRs in two languages and the wheels fall off.
The Australian desert circus I crossed years ago taught me something that applies here. The performers who drew the biggest crowds weren't the most technically gifted. They were the ones whose act worked in any weather, any town, any audience. Fire chains beat aerial silks every time. Robust beats impressive.
Healthcare AI that works in production has to be robust at the patient interaction layer, not impressive in the demo. Different game.
What metrics should a CMO actually care about?
Three. Engagement rate, adverse event rate, and time-to-deployment.
Engagement rate, because if patients don't answer the AI, none of the rest matters. Industry baseline for patient outreach is 15 to 20%. If a vendor can't show you a multiple of that, they're selling vapor.
Adverse event rate, because this is the only number that determines if your platform is still operating in three years. HANA has run over 1M patient interactions with zero critical adverse events, and I'll tell you exactly how we got there if you ask. It's not luck. It's a paranoid amount of guardrail engineering.
Time-to-deployment, because the platforms that take 9 months to go live are platforms you've already paid for nine months without seeing value. Look at real case studies, not the brochure timelines.
Does the platform's pricing model tell you something about its design?
It tells you everything.
Per-seat pricing means the vendor thinks the bottleneck is human licenses. Per-call or per-interaction pricing means they think the bottleneck is patient throughput. Fixed-fee per provider means they have no idea and they're hoping you don't either.
For voice AI patient outreach the cleanest model is per-call, because the unit of value is the completed conversation. HANA's pricing page shows the actual math. If you can't draw a line from a single call to a clinical or financial outcome, the pricing model is hiding something. That's true whether you're buying voice AI, scribe AI, or any other piece of the stack.
Key Takeaways
The AI platforms that will still be standing in 2028 won't be the ones with the longest feature list. They'll be the ones that picked a single high-friction workflow, attacked it with proprietary infrastructure rather than wrappers, and built proof at scale before they ever wrote a press release.
If you're a CMO or CIO evaluating platforms right now, the question isn't "what can it do?" The question is "what does it refuse to do, and why?" The vendors who can answer that with conviction are the ones building something that'll last. Everyone else is selling you ten platforms duct-taped together with a logo on top.
That's a hard sell to make a board excited about. It's also the only kind of platform worth signing for.
FAQ
What's the difference between a wrapper and a real AI platform?
A wrapper sends your data to a third-party model and renders the response back inside an existing app. A real AI platform owns the model layer, the orchestration, and the safety guardrails as one stack. The difference shows up the first time your model provider has an outage.
How long should a healthcare AI deployment take?
For a focused single-workflow platform like voice follow-up, 2 to 6 weeks is realistic. Multi-workflow platforms usually take 6 to 9 months and that's not a feature, that's a warning sign about how complex the integration is. If you want to walk through what a deployment looks like for your team, book a call.
Should we build AI infrastructure in-house?
Almost never for clinical workflows. The regulatory surface, evaluation harnesses, and 24/7 monitoring you need are not what a hospital IT team should be building from scratch. Buy the platform, own your data, and make sure the vendor can demonstrate production scale across multiple deployments.
